Trial intelligence / Profile preview

Etanercept vs. Tofacitinib in Rheumatoid Arthritis

NCT03976245Phase 4Recruiting

Start
Mar 2020
Primary completion
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tofacitinib oral solution in rheumatoid arthritis (RA). Started Mar 2020; status: recruiting.

02

Drugs

tofacitinib oral solution
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT03976245.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03976245.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call